Washington, D.C. – On 2-3 December 2013, world leaders gathered in Washington D.C. to demonstrate global unity in a launch of funding commitments for the fight against AIDS, TB and malaria over the next three years. An initial amount US$12.0 billion was pledged in contributions from 25 countries, as well as the European Commission, private foundations, corporations and faith-based organizations. That represented the largest amount ever committed to fight against AIDS, tuberculosis and malaria. It was a 30 percent increase over the US$9.2 billion in firm pledges secured in 2010 at the start of the 2011-2013 period.
At the Replenishment launch, global leaders voiced a broad consensus that we are at a historic moment in the fight to defeat AIDS, TB and malaria. Scientific advances are giving us the ability to completely control these diseases. Harnessing these funds, we can make a transformational difference in the lives of millions of people.
Note: Amounts represent nominal pledges and may be modified, up or down, to reflect donor-specified and other adjustments as the case may be.
|DONOR GOVERNMENTS||2014-2016 in millions
|2014-2016 in millions (USD)|
|European Commission||EUR 370.0||502.9|
|United Kingdom||GBP 1,000.0||1,636.90|
|United States of America||–||4,002.30|
|Cote d’Ivoire (D2H*, Germany)||XOF 3,109.2||6.4|
|Indonesia (D2H*, Australia)||EUR 3.4||4.7|
|Indonesia (D2H*, Australia)||–||5.4|
|PRIVATE SECTOR DONORS|
|Bill & Melinda Gates Foundation (BMGF)||Promissory Note||300|
|Bill & Melinda Gates Foundation (BMGF)||Cash||200|
|RED (Consumer Marketing Initiatives)||40|
|United Methodist Church||19.9|
An Article from Forbes Posted 3/19/2013 @ 8:00AM
By John Lechleiter, Contributor
One of the most severe cases of drug-resistant tuberculosis in the United States has been reported in southern Texas: a strain of TB resilient to at least eight of the 15 drugs used to treat this deadly airborne disease. This report comes hot on the heels of news that South Africa has become the fourth country – after India, Iran and Italy – to register strains of TB that can overpower at least 10 of these drugs.
As we mark World TB Day on Sunday March 24, there can be no denying that TB, fueled by drug resistance, continues to pose a serious global health threat – one that must be urgently addressed. An outbreak of drug-resistant TB in New York City in the early 1990s cost more than $1 billion and killed 29 Americans. With resistance spreading, we need a renewed global commitment that combines public and private efforts to defeat TB.
According to the World Health Organization, more than eight million people became infected with TB and 1.4 million died in 2011 – that’s about the entire population of Greater Indianapolis, the city where I live. And between 2009 and 2011, drug-resistant TB cases doubled in the 27 most-affected countries.
Yet there are plenty of reasons to be optimistic. New partnership models are marshaling the resources and knowledge required to produce new TB innovations that can outflank the disease – and ensure that patients benefit from them.
For example, Cepheid has developed a rapid diagnostic test, GeneXpert, which can identify TB – and the presence of drug-resistant bacteria – in about two hours. The U.S. government and the Bill & Melinda Gates Foundation are now collaborating in countries with high TB burdens to subsidize the purchase of these state-of-the-art tools.
A team from the Pacific Friends of the Global Fund is currently attending the 2012 Asia-Pacific Development Summit in Jakarta. Between 3 and 5 September participants at the summit are discussing how ‘Public-Private Partnerships can close regional health MDG gaps.
The Indonesian Health Ministry will play a leading role in hosting the conference, partnering with the Bill & Melinda Gates Foundation, the ASEAN Foundation, and the Office of the Special Envoy on MDGs to the President of the Republic of Indonesia. Representatives of public and private sectors from six ASEAN member countries and several countries outside the region, including China, India and the United States are in attendance. Amongst the participants are representatives from the Global Fund to Fight AIDS, Tuberculosis and Malaria, and the Oil Search Health Foundation. Speakers addressing the summit include World Health Organization director general Margaret Chan, Indonesian Deputy Health Minister Ali Ghufron Mukti and ASEAN Secretary-General Surin Pitsuwan.
Last week, the director for maternal health of the Indonesian Health Ministry, Gita Maya Koemara Sakti, said that the conference aimed at promoting the strong partnerships between public and private sectors needed for an integrated strategy to improve public health, in particular child and maternal health, and to accelerate progress towards achieving the MDGs by 2015.
The aim of the high-level Development Summit is to identify multi-sectoral initiatives that:
- strengthen regional networks and policy coordination to address health challenges;
- amplify the voices of health officials and health stakeholders;
- catalyse public-private partnerships to close health MDG gaps.
Public-private partnerships have been a driving force behind the life-saving work of the Global Fund, which to date, has prevented the deaths of an estimated 8.7 million lives through treatment and disease prevention. The Global Fund has been instrumental in realising MDG 6 to combat HIV/AIDS, malaria and other diseases, and currently provides round 80 per cent of international funding for tuberculosis, 50 per cent for malaria and approximately 20 per cent for HIV.
The monumental impact of the GAVI Alliance got the spotlight on the second day of the Summit. Chris Elias, President of Global Development at the Bill & Melinda Gates Foundation held a compelling presentation about the miracle of vaccines. Shortly followed by a panel discussion in which Deputy CEO of the GAVI Alliance, Helen Evans, highlighted some of the successes of immunisation.
Today, during the last day of the Summit, traditional and emerging Asia-Pacific development partners will further deepen the conversation to find ways to collectively advance health priorities in the region, and elevate health MDG gaps to the agenda of region fora.
Every year, since 2009, Bill Gates publishes an annual letter in which he address some pertinent global matters and the progress that has been made in the previous year. He covers a wide range of topics in this year’s letter, including innovation in agriculture (including food security), global health (including vaccines, polio, AIDS and the Global Fund, family planning, and population growth), U.S. education, and updates on the work of his Foundation.
In his Global Health section he emphasises once again the importance of the work of the Global Fund:
Between 2008 and 2010 the Global Fund gave $8 billion for AIDS (57 percent), malaria (29 percent), and tuberculosis (14 percent). Other than PEPFAR for AIDS, the Global Fund is the biggest donor for all three of these diseases. It provided the money for 230 million bednets, which have been key to the 20 percent decline in malaria deaths over the past decade. It also provided treatment for 8.6 million cases of tuberculosis. I am not doing a section on malaria or TB in this year’s letter, but there has been good progress in both diseases, with the Global Fund being key to this.
The Global Fund does a lot to make sure its money is spent efficiently. Given the places where the Global Fund works, it is not surprising that some of the money was diverted for corrupt purposes. However, the Global Fund found these problems itself and changed the way it handled training grants, where most of the problems were. Unfortunately, news of any corruption makes many citizens think the entire program is mismanaged and a huge portion of the money is being wasted. Some of the headlines that talked about two-thirds of specific grants being misdirected fueled this impression. In fact, less than 5 percent of Global Fund money was misused, and with the new procedures in place that percentage will be even lower. Our foundation is the biggest non-government supporter of the Global Fund, committing $650 million over the years because of the incredible impact its spending has. I am confident that this is one of the most effective ways we invest our money every year, and I always urge other funders to join us in getting so much bang for our buck.
Between 2011 and 2013, assuming that all donors honor their commitments, the Global Fund will disburse $10 billion. This is a $2 billion increase, but not nearly the $12–$14 billion that is needed and was hoped for. Citizens of donor countries should know about the difference their generosity has made. The cost of keeping a patient on AIDS drugs has been coming down, and it looks like getting it to $300 per patient per year should be achievable. That will mean every $300 that governments invest in the Global Fund will put another person on treatment for a year. Every $300 that’s not forthcoming will represent a person taken off treatment. That’s a very clear choice. I believe that if people understood the choice, they would ask their government to save more lives.
Bill and Melinda Gates explained on 27 October 2009 why they are Impatient Optimists in a speech from Sidney Harmon Hall in Washington, D.C. screened live at the Lowy Institute for International Policy.
The speech launches the Living Proof Project which highlights the extraordinary successes that have resulted from the greatly increased support of global public health programs by the United States government and the Bill & Melinda Gates Foundation.
The Living Proof Project demonstrates that initiatives to fight malaria, AIDS, and other diseases are saving and improving the lives of millions of people in poor and developing countries – and as a result, empowering them to lead more productive lives. The launch of Living Proof comes at a time when the global financial crisis may impose severe constraints on the capacity of the United States and other traditional large donor countries to increase their development assistance and global health budgets. It is therefore a decisive and welcome intervention in the emerging public debate about the future funding and direction of development assistance that will have a significant impact not only in the United States but in Australia and globally.
Bill and Melinda are optimists since there have been some major improvements in global public health over the last decades due to the greatly increased support from the United States government and the Bill & Melinda Gates Foundation. Bill showed that child mortality has gone down from 20 million deaths a year in 1960 to less than 9 million in 2008. Focusing on the world’s most killing diseases they presented some striking global facts: smallpox is eradicated, polio is reduced by 99%, measles by 93%, and in the fight against HIV and AIDS there is a significant increase in mothers that are on preventive drugs, while since 2004 some 190 million bednets have been delivered world wide to fight malaria.
Yet, Bill and Melinda are also impatient because so much more can be done, right now. Why are there still many people dying of malaria while the disease is preventable and treatable? Fortunately, as Bill said “we got great science and more resources”, and that is what makes them impatient optimists. The key message Bill and Melinda thus offered is that “spending on global health is the best investment we make for saving lives”.
In this important multimedia presentation, Bill and Melinda Gates personally addressed senior policy-makers and opinion leaders in Washington, DC and around the globe to highlight opportunities to build on global health successes, and to develop the main themes of the Living Proof project.
The Lowy Institute for International Policy enjoys a close relationship with the Bill & Melinda Gates Foundation, which funds the Pacific Friends of the Global Fund to Fight AIDS, Tuberculosis and Malaria within the Lowy Institute.
Supporting the work of the Bill & Melinda Gates Foundation is imperative, and the Lowy Institute was therefore pleased to facilitate the direct screening of this influential presentation.
Watch the “Why We Are Impatient Optimists” presentation below: